SCHEMBL12420323

SCHEMBL12420323

CCCC[C@@H](CO)OC(C)=O

nearest known ligand 0.61

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PRKCA P17252 5/20 0.56
MAPT P10636 2/20 0.48
MAPK1 P28482 1/20 0.48
PRKCD Q05655 2/20 0.42
PRKCE Q02156 1/20 0.42
PRKCQ Q04759 1/20 0.42
GLS2 Q9UI32 3/20 0.40
ALDH1A1 P00352 3/20 0.40
FAAH O00519 1/20 0.39
HPGD P15428 1/20 0.39
CNR1 P21554 1/20 0.39
CNR2 P34972 1/20 0.39
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CTSK P43235 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2959330 1.00 PRKCA (0.56) PRKCAMAPTMAPK1PRKCDPRKCE
Ether SCHEMBL9615811 0.93 PRKCA (0.50) PRKCAMAPTMAPK1PRKCDPRKCE
SCHEMBL28489536 0.92 PRKCA (0.61) PRKCAMAPTMAPK1PRKCDPRKCE
SCHEMBL10846866 0.92 PRKCA (0.61) PRKCAMAPTMAPK1PRKCDPRKCE
SCHEMBL9330070 0.92 PRKCA (0.61) PRKCAMAPTMAPK1PRKCDPRKCE
SCHEMBL15902853 0.92 PRKCA (0.61) PRKCAMAPTMAPK1PRKCDPRKCE
SCHEMBL3469987 0.90 PRKCA (0.59) PRKCAMAPTMAPK1PRKCDPRKCE
SCHEMBL29144896 0.90 PRKCA (0.59) PRKCAMAPTMAPK1PRKCDPRKCE
SCHEMBL8669152 0.89 PRKCA (0.47) PRKCAMAPTMAPK1PRKCDGLS2
SCHEMBL22531093 0.87 PRKCA (0.50) PRKCAMAPTMAPK1PRKCDPRKCE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7989602-B2 having biological activity similar to PIM (acyl glycerol phosphatidylinositol manno-oligosacccharide) activity; asthma, allergic rhinitis, dermatitis, psoriasis, inflammatory bowel disease including Crohn's disease and ulcerative colitis, rheumatoid arthritis, multiple sclerosis, diabetes, systemic lupus THE MALAGHAN INSTITUTE OF MEDICAL RESEARCH (NZ) 2011-08-02 US disclosed